(Q53610821)

16 May 2018

title

Results of intensive long-term treatment of familial hypercholesterolemia. (English)

1 reference

16 May 2018

0 references

Retterstøl K

1

1 reference

16 May 2018

Stugaard M

series ordinal

2

1 reference

16 May 2018

Gørbitz C

series ordinal

3

1 reference

16 May 2018

Ose L

series ordinal

4

1 reference

16 May 2018

language of work or name

English

0 references

publication date

1 December 1996

1 reference

16 May 2018

American Journal of Cardiology

published in

1 reference

16 May 2018

volume

78

1 reference

16 May 2018

issue

12

1 reference

16 May 2018

page(s)

1369-1374

1 reference

16 May 2018

A receptor-mediated pathway for cholesterol homeostasis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900649-2

Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900649-2

Cost-effectiveness considerations in the treatment of heterozygous familial hypercholesterolemia with medications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900649-2

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900649-2

N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900649-2

Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900649-2

The factor structure of the General Health Questionnaire (GHQ-30). A reliability study on 6317 community residents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900649-2

Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900649-2

Prediction of serum-cholesterol responses of man to changes in fats in the diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900649-2

Lp(a) lipoprotein in cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900649-2

Body mass index from childhood to middle age: a 50-y follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900649-2

Overview of current issues in management of dyslipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900649-2

HMG CoA reductase inhibitors and quality of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900649-2

On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900649-2

Co-enzyme Q10: a new drug for cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900649-2

Serum ubiquinone concentrations after short- and long-term treatment with HMG-CoA reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900649-2

10.1016/S0002-9149(96)00649-2

7 January 2021

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018